Flucozole

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flucozole

Quick Facts Overview

Property Description
Active ingredient Fluconazole
Pharmacological class Triazole Antifungal Agent
Forms Tablets, Capsules, Sterile Solution
Common purpose Systemic treatment of fungal infections
Origin Synthetic Compound

Defining Flucozole: A Systemic Triazole Antifungal

Flucozole is a name representing a medicine containing the active ingredient Fluconazole, which is classified as a synthetic triazole antifungal agent. This product belongs to the broader pharmacological class of Antifungal Agents. Fluconazole is recognized in medical literature for its high oral bioavailability, a characteristic that supports its efficacy for internal use. As a synthetic compound, it represents a dedicated advancement in targeted systemic anti-fungal therapy.


Composition, Forms, and General Purpose

The medication is a single-ingredient product, containing only Fluconazole as its primary compound. Flucozole is supplied in multiple dosage forms for systemic administration, including tablets or capsules for oral use, and a sterile solution for intravenous use. Fluconazole is primarily intended for systemic treatment, ensuring effective action across various body compartments. This capability is fundamental to the drug's general purpose: providing effective management and control of fungal and yeast infections that require internal, widespread intervention.


Fundamental Principle of Action

Fluconazole works by employing a fungistatic principle that prevents the fungal cells from properly constructing their protective outer layer. The active ingredient specifically interferes with the production of ergosterol, a vital structural component of the fungal cell membrane, which is a mechanism for stopping the fungus's ability to multiply and spread. This targeted action is fundamental to allowing the patient’s own immune system to overcome the infection, leading to its control and eventual resolution.

Regulatory References

  1. Fluconazole: MedlinePlus Drug Information

What side effects are possible with Flucozole?

Possible Side Effects and Safety Information

The safety profile of Flucozole (Fluconazole) is formally structured by regulatory authorities based on the frequency and system-organ class of adverse reactions reported. The most frequently observed effects are classified as Common, occurring in up to 1 in 10 individuals, and primarily involve Gastrointestinal Disorders (e.g., nausea, abdominal pain, diarrhea) and Nervous System Disorders (e.g., headache).

Less frequently, adverse reactions are classified as Uncommon or Rare, and may affect the Hepato-biliary System or the Skin and Subcutaneous Tissue. Serious adverse reactions, though rare, are highlighted in official labeling and include severe forms of hepatic injury, such as Hepatic Failure, and life-threatening dermatological conditions, such as Stevens-Johnson syndrome and Toxic Epidermal Necrolysis.

Official Safety Constraints

The label defines specific safety constraints for use. Cardiac Disorders are a key consideration, as the medication has been associated with rare cases of QT interval prolongation and Torsade de Pointes. For this reason, co-administration is strictly contraindicated with certain other medications known to prolong the QT interval.

Safety notes also address specific patient populations. Caution is required for patients with pre-existing Renal Impairment or Hepatic Impairment, and the official documents guide monitoring in these groups. Furthermore, the medication is contraindicated in individuals with known hypersensitivity to Fluconazole or related azole compounds.

Overdose and Emergency Response

Overdose and when to seek help

Recognising an Overdose

Official regulatory reports have documented instances of fluconazole overdose that were accompanied by specific neuropsychiatric effects, including hallucination and paranoid behavior. While an overdose may present with these or other symptoms, it is critical to seek immediate medical assistance for any suspected exposure above the prescribed amount.

When to Seek Emergency Medical Help

Always call a doctor or a Poison Control Center immediately in the event of an accidental or suspected overdose, even if no symptoms are apparent. Overdose situations require urgent medical attention and must be managed by healthcare professionals.

Overdose Management

Management of fluconazole overdose is symptomatic and supportive. This approach focuses on treating the acute symptoms and maintaining vital functions. Depending on the clinical assessment, procedures such as gastric lavage may be instituted if clinically indicated.

Fluconazole is primarily eliminated from the body through the urine. Clinical data indicates that the drug can be partially removed from the body using hemodialysis; a three-hour hemodialysis session can decrease plasma concentrations by approximately 50%. The decision to use hemodialysis rests with the medical team based on the patient's condition.

Therapeutic Uses of Flucozole

Flucozole is prescribed to support the management of symptoms associated with various fungal infections, primarily those caused by Candida and Cryptococcus organisms. Its therapeutic role is to aid in addressing a range of clinical scenarios, helping to achieve symptomatic improvement across affected areas. The medication is used to alleviate discomfort in conditions such as oropharyngeal and esophageal candidiasis (thrush), and vaginal candidiasis. In more serious, systemic cases, Flucozole is part of the treatment approach for candidemia and cryptococcal meningitis, contributing to the resolution of active infection signs. It may also be administered in certain high-risk patient groups to assist in preventing the onset of Candida infections.

“The goal of treatment is to manage symptoms and support the body’s recovery from fungal overgrowth.”

Quick Fact: Flucozole is utilized to manage the symptoms of fungal and yeast infections, supporting the body’s ability to clear the underlying cause.

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Fluconazole

This information reflects official eligibility constraints and prohibitions for Fluconazole as defined by regulatory bodies (e.g., FDA, EMA).


Contraindications (Must Not Use)

  • Known Hypersensitivity: Individuals with a documented allergy to fluconazole, related azole antifungals, or any excipients present in the specific formulation.
  • Concomitant Medications: Patients taking certain drugs that prolong the QT interval and are metabolized by the CYP3A4 enzyme (e.g., pimozide, cisapride, high-dose terfenadine) due to the risk of serious cardiac events.

Restricted/Conditional Use

Population/Condition Restriction/Requirement
Renal Impairment Requires mandatory dose reduction after the initial loading dose (e.g., for Creatinine Clearance leq 50 mL/min).
Hepatic Dysfunction Requires close patient monitoring and administration with caution due to the risk of hepatic injury.
Pregnancy/Lactation Generally avoided in pregnancy, especially chronic, high-dose use during the first trimester. Used only when anticipated benefit outweighs the risk.
Neonates/Infants Use is established but conditional on developmental status, requiring specific, extended dosage intervals for infants leq 4 weeks old.

Fluconazole use is permissible in adults and older children but is strictly prohibited or limited by these specific physiological and co-medication constraints.

What should I know about interactions with other medicines?

Fluconazole is a potent inhibitor of certain cytochrome P450 (CYP) enzymes, specifically CYP2C9 and CYP2C19, and a moderate inhibitor of CYP3A4. This enzyme inhibition is the primary mechanism for numerous drug-drug interactions, leading to increased plasma concentrations of co-administered medicines that rely on these enzymes for metabolism.

Contraindicated Combinations: Co-administration is strictly contraindicated with drugs known to prolong the QT interval and which are metabolized via CYP3A4, as this significantly increases the risk of serious cardiac rhythm disturbances like Torsades de Pointes. Specific contraindicated agents include cisapride, astemizole, pimozide, quinidine, erythromycin, and terfenadine (at fluconazole doses ge 400 mg/day).

Interactions Requiring Monitoring and Adjustment:

  • Anticoagulants (e.g., warfarin): Fluconazole inhibits warfarin metabolism via CYP2C9, necessitating close monitoring of the International Normalized Ratio (INR) and potential reduction of the warfarin dose to manage the increased risk of bleeding. The effect can persist for several days after fluconazole is stopped.
  • Immunosuppressants (e.g., cyclosporine, tacrolimus): Plasma concentrations are significantly increased, requiring dose reduction and continuous monitoring of immunosuppressant levels and renal function.
  • Oral Hypoglycemics (e.g., sulfonylureas): Co-administration increases the risk of hypoglycemia and requires frequent blood glucose monitoring.
  • Rifampicin: This antitubercular agent is an enzyme inducer that can decrease fluconazole exposure by approximately 25%, potentially requiring a fluconazole dose increase.
  • Statins (e.g., atorvastatin, simvastatin): The risk of muscle disorders like myopathy and rhabdomyolysis is increased, requiring careful observation and potential discontinuation of the statin.

Mechanism of Action

Fungal Enzyme Inhibition

Fluconazole exerts its primary action by selectively inhibiting the fungal enzyme Lanosterol 14-alpha-demethylase (CYP51). This interaction is central to the drug's mechanism, setting off a cascade that affects the ergosterol biosynthesis pathway, which is unique to fungal membranes.

Disruption of Ergosterol Biosynthesis

The inhibition of the enzyme (CYP51) disrupts the entire ergosterol biosynthesis pathway, which is responsible for producing ergosterol, the primary sterol of the fungal cell membrane. The resulting depletion of ergosterol and the buildup of intermediary sterols compromise the structural and functional integrity of the fungal membrane.

Physiological Effect: Fungal Growth Arrest

The cascade, from enzyme binding to membrane damage, results in the final physiological effect: fungistasis, or the arrest of fungal cell growth and proliferation. This inhibition of replication results in the functional arrest of the fungal cell population.

Dosage and Administration Information

How to Use Fluconazole

Fluconazole is administered via the oral route (capsules or suspension) or by intravenous (IV) infusion. The dose and duration of treatment are determined by the prescribing healthcare provider based on the specific condition being treated.

Administration Details

The medication is generally taken once daily and may be administered with or without food. For certain multi-day regimens, official instructions specify a loading dose—which is typically twice the daily maintenance dose—administered on the first day to more quickly achieve effective drug concentrations in the body. The full prescribed course of treatment must be completed as directed.

Preparation and Special Conditions

Administration Factor Official Instruction
Oral Suspension The liquid suspension must be shaken well before each use and accurately measured using a calibrated device provided by the pharmacist.
IV Administration The rate of intravenous infusion must not exceed 10 mL per minute. The daily dosage is the same whether given orally or intravenously.
Renal Impairment Dosage adjustments (reduction) are required for patients with impaired kidney function based on the physician's assessment of creatinine clearance.
Pediatric Use Dosing for children is calculated based on body weight (mg/kg) and is generally administered once daily.

These instructions define the standardized procedures for taking the medication.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Flucozole

The information below describes the type of research that has been conducted on Flucozole (Fluconazole). It outlines what studies have explored and what outcomes they have monitored, but it does not offer any clinical advice or individual recommendations.


Evidence for Use in Common Fungal Infections

Research Context for Oropharyngeal Candidiasis (Oral Thrush)

Short-term Randomized Controlled Trials (RCTs) and clinical studies have examined the use of Flucozole in contexts related to oral thrush. These studies monitored outcomes related to physical discomfort and the evolution of physical signs. Outcomes included the assessment of clinical cure rates, research examining symptom change, and mycological cure rates (evidence of fungal clearance).

Findings describe patterns observed in these studies. However, evidence remains limited regarding the long-term patterns of this condition after the study period, particularly in patients who may be at a higher risk for recurrent episodes.

Research Context for Vaginal Candidiasis (Yeast Infection)

The evidence structure for vaginal yeast infections includes Randomized Controlled Trials and comparative studies. Researchers focused on outcomes related to irritative states. The studies measured the documentation of clinical cure and mycological cure, and in some cases, the evaluation of relapse or recurrence rates.

Findings describe patterns of change assessed shortly after the study period. While some research tracked patterns of recurrence for up to six months, there is limited information for long-term outcomes regarding prevention across all studied populations.


Evidence for Use in Systemic and Invasive Infections

Research Context for Candidemia (Bloodstream Infection)

Research related to systemic Candida infections was evaluated in Randomized Controlled Trials and meta-analyses. These studies explored outcomes reflecting systemic or functional imbalance, including documentation of survival rates, clinical success rates, and the tracking of fungal clearance from blood cultures. Data show patterns that may vary depending on the specific Candida species involved and the patient’s underlying severity of illness.

Research Context for Cryptococcal Meningitis

Studies were evaluated in Randomized Controlled Trials primarily focusing on adults with underlying HIV/AIDS. Research monitored outcomes over long periods, including survival, fungal clearance from the cerebrospinal fluid (CSF), and the evaluation of relapse prevention. The evidence base focuses heavily on the HIV-positive population, and data for certain groups, such as individuals without HIV infection, remain insufficient.

Frequently Asked Questions (FAQ)

Common questions about Flucozole (FAQ)


Q: How quickly should I expect to see an improvement after starting Flucozole?

A: Regulatory information describes a mechanism that begins to interfere with fungal growth quickly. This is supported by the use of an initial loading dose in certain treatments to help achieve effective drug concentrations rapidly. However, the time it takes to see a noticeable clinical improvement can vary significantly depending on the type and severity of the infection being treated.

Q: How long does Flucozole stay in your system after you stop taking it?

A: Official information indicates that Flucozole can remain in the body for an extended period after the last dose. For example, the effect of the drug's interaction with blood thinners like warfarin is known to persist for several days after Flucozole treatment has stopped. This presence must be considered when starting or stopping other medications.

Q: Can Flucozole affect my liver test results?

A: Yes, official safety information indicates that adverse reactions affecting the hepato-biliary system (liver and gallbladder) have been reported, though they are uncommon. Serious effects like hepatic failure are rare but documented. Due to the potential for severe liver effects, official information notes that monitoring may be required for patients with pre-existing liver conditions.

Q: Is Flucozole safe for older adults or seniors?

A: Flucozole is permissible for use in adults, including seniors. However, because the drug is primarily cleared by the kidneys, and kidney function often declines with age, patients who have impaired kidney function may require a dosage adjustment. Treatment is conditional upon the patient's overall health and physiological function.

Q: What happens if I miss a dose of Flucozole?

A: Official instructions emphasize that the full prescribed course of treatment must be completed to ensure the infection is fully resolved. If a dose is missed, regulatory information does not provide a standard instruction. A healthcare professional can provide specific guidance for managing a missed dose.

Q: Is Flucozole used to treat athlete's foot?

A: Official research and product information primarily outline the role of Flucozole in treating conditions like oral and vaginal candidiasis, and systemic fungal infections. The documents emphasize its systemic use for internal infections, rather than solely superficial topical conditions like athlete's foot.

Q: Can Flucozole be used for infections in the nails?

A: Flucozole is supplied in forms intended for systemic (internal) administration, which allows it to reach infections that are difficult to treat with topical creams, such as fungal infections in the nails (onychomycosis). The decision and duration of treatment are based on the clinical assessment by a healthcare professional.

Q: Is Flucozole generally considered safe during pregnancy?

A: Official constraints state that Flucozole is generally avoided in pregnancy, particularly for chronic, high-dose use during the first trimester. The medication should be used during pregnancy only if a healthcare professional determines that the potential benefit justifies the potential risk to the fetus.

Q: Is it important to keep track of any unusual fatigue while on Flucozole?

A: While fatigue itself is not listed as a common side effect in official documents, Flucozole is associated with rare but serious hepatic (liver) injury. Since liver problems can sometimes cause fatigue, it is important for patients to inform a healthcare professional if they experience significant or unusual fatigue while taking this medication.

Q: Are there any specific foods or drinks I need to avoid while on Flucozole?

A: Flucozole may be administered with or without food because its oral absorption is not significantly affected by meals. Official information regarding co-administration notes that alcohol use should be discussed with a healthcare professional due to potential interactions or increased risk of liver-related effects.

Q: What is the typical duration of a Flucozole treatment course?

A: The required duration of Flucozole treatment can vary widely. For simple infections, a single dose may be used. For more serious or systemic infections, treatment may last for several weeks or even months. The total course is tailored by the prescriber based on the specific infection and the patient’s clinical response.

Q: Why is proper hydration important when taking Flucozole?

A: Flucozole is primarily eliminated from the body via the kidneys. For the drug to be cleared efficiently, healthy kidney function is important, and dosage adjustments are necessary if kidney function is impaired. Maintaining good overall health, including hydration, supports the body's processes for drug clearance.

Q: Can children use Flucozole and are there different formulations for them?

A: Yes, Flucozole use is established for children, with dosing specifically calculated based on body weight. The medicine is available as an oral suspension (liquid) which can be easier for children to take, as well as tablets and capsules.

Q: Does Flucozole make you more sensitive to the sun?

A: Flucozole belongs to a class of antifungals (azoles) where some members have been associated with photosensitivity (increased sensitivity to sunlight). While rare, severe skin reactions are reported with Flucozole, suggesting caution regarding excessive sun exposure is appropriate.

Q: Does alcohol consumption interfere with Flucozole's effectiveness?

A: Official information does not specifically state that alcohol interferes with Flucozole's effectiveness. However, because alcohol can affect the liver, and Flucozole is also associated with potential liver-related side effects, official information notes that alcohol use should be discussed with a healthcare professional.

Q: Is it true that Flucozole can cause changes in taste or smell?

A: Yes, official adverse reaction reports indicate that changes in taste, known as dysgeusia, as well as an unpleasant or unusual aftertaste, have been associated with fluconazole use. These sensory changes are reported as potential adverse effects of the medication.

Q: Why do some people need to take Flucozole for a longer period than others?

A: The required duration of Flucozole treatment is highly variable because it depends on the complexity of the infection and the patient's individual response. Patients with systemic infections or those who are immunocompromised may require a longer course of treatment or continuous maintenance therapy.

Q: Can Flucozole interact with herbal supplements like St. John's Wort?

A: Flucozole has the potential to interact with many different substances because it affects certain enzymes that process other drugs. A healthcare professional should be consulted regarding the use of all supplements and herbal remedies, as Flucozole's interaction potential with these substances may not be fully established in official documents.

Q: Is the absorption of Flucozole affected by taking it with food?

A: No, regulatory documents confirm that Flucozole's oral absorption into the body is excellent and is not significantly affected by food. Therefore, the medication can be taken with or without food.

Q: Are there any known long-term effects of taking Flucozole multiple times?

A: Official safety data highlights that serious reactions, like severe hepatic (liver) injury, are a consideration, especially with long-term or repeated use. Additionally, hair loss (alopecia) has been reported, particularly in patients who receive prolonged therapy.

Q: What is the maximum number of days a person can safely be on Flucozole?

A: There is no single maximum duration; the treatment length is based on the specific condition. Treatment for certain severe systemic infections or for maintenance therapy in specific patient groups may need to extend for many months or even indefinitely, under continuous medical supervision.

Q: Can taking Flucozole affect your sleep patterns?

A: Nervous system disorders, including headache, are listed as common side effects of Flucozole. Although specific disruptions to sleep patterns like insomnia are not commonly listed, any medication that affects the nervous system has the potential to impact sleep, and any concerns should be reported to a healthcare professional.

Q: Is it okay to crush or chew the Flucozole tablet if I have trouble swallowing pills?

A: The official instructions for Flucozole tablets do not advise crushing or chewing the medication. The oral suspension (liquid form) is available for patients who have difficulty swallowing tablets.

Q: Does Flucozole interact with common cold or flu medications?

A: Flucozole can interact with medications metabolized by key enzymes in the body. Because some cold and flu remedies contain substances processed by these same enzymes, it is necessary to disclose all co-administered medications, including common cold and flu remedies, to a healthcare professional.

Q: Can taking Flucozole cause temporary hair thinning or loss?

A: Yes, alopecia, which is the medical term for hair loss, has been listed as an uncommon adverse effect associated with Flucozole. This side effect is reported more frequently in patients who are on prolonged therapy.

Q: Is it safe to exercise heavily while taking Flucozole?

A: Heavy exercise is not directly restricted in regulatory documents. However, caution is advised because Flucozole is associated with rare cases of liver and muscle issues, especially when co-administered with statins. Any unusual physical symptoms during exercise should be reported to a healthcare professional.

Q: How effective is Flucozole against drug-resistant fungal strains?

A: Official microbiology information indicates that resistance to Flucozole has been reported in certain types of Candida, such as C. krusei and C. glabrata. If resistance is confirmed, an alternative antifungal medication may be necessary to resolve the infection.

Q: Why do people sometimes need a single, high dose of Flucozole instead of a longer course?

A: Single-dose therapy is generally reserved for conditions that are uncomplicated and acute, such as acute vaginal candidiasis. This dosing strategy is intended to deliver a rapid, high concentration of the drug to the site of infection.

Q: Are there any restrictions on driving or operating machinery while taking Flucozole?

A: Official documents state that side effects such as dizziness or seizures may occasionally occur with Flucozole. If these symptoms are experienced, the ability to drive or operate machinery may be affected.

How should Flucozole be stored and disposed of?

Official Storage and Disposal Requirements

Fluconazole storage and disposal requirements are strictly defined by regulatory labeling to maintain potency and safety.

Requirement Category Official Instructions
Storage Temperature Store tablets and dry powder below 30 C (86 F).
Handling / Environment Protect all liquid forms, including the injection solution and oral suspension, from freezing. Avoid excessive heat.
Stability / Shelf-Life Discard any unused portion of the reconstituted (mixed) oral suspension after 14 days.
Container Protection Keep the medicine in its original container and ensure the container is tightly closed.
Child Safety Keep fluconazole and all other medicines out of the sight and reach of children.
Disposal Safely throw away any expired or no longer needed product by following official governmental guidelines for medicine disposal.

These instructions ensure the product remains stable for the duration of use and is discarded in a manner that protects the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Flucozole found in:

A-Z Index: